Vertex Pharmaceuticals Inc. Profit Climbs In Q2
(RTTNews) - Vertex Pharmaceuticals Inc. (VRTX) announced earnings for its second quarter that Increases, from the same period last year
The company's earnings came in at $1.099 billion, or $4.31 per share. This compares with $1.032 billion, or $3.99 per share, last year.
Excluding items, Vertex Pharmaceuticals Inc. reported adjusted earnings of $1.207 billion or $4.73 per share for the period.
The company's revenue for the period rose 12.4% to $3.333 billion from $2.964 billion last year.
Vertex Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings: $1.099 Bln. vs. $1.032 Bln. last year. -EPS: $4.31 vs. $3.99 last year. -Revenue: $3.333 Bln vs. $2.964 Bln last year.
-Guidance: Full year revenue guidance: $ 13.1 B To $ 13.2 B
Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.